Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Strzelczyk

Showing results (241-250 of 295) with videos related to

Pageof 30
Sort By:
Epilepsia|October 19, 2016
Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from GermanyLena-Marie Kortland, Anne Alfter, Oliver Bähr, et al.
Critical Care Medicine|August 28, 2023
The Long-Term Use of Diagnostic Subdural Electroencephalogram Electrodes and Subdural Hematoma: A Prospective Cohort StudySae-Yeon Won, Thomas M Freiman, Sara Sujin Lee-Müller, et al.
Epilepsia|August 4, 2015
Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in GermanyJanna Riechmann, Adam Strzelczyk, Jens P Reese, et al.
Epilepsy & Behavior : E&B|October 25, 2019
Can commercially available wearable EEG devices be used for diagnostic purposes? An explorative pilot studyYannic Titgemeyer, Rainer Surges, Dirk-Matthias Altenmüller, et al.
Epilepsy & Behavior : E&B|July 6, 2024
Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studiesEdward Faught, Hervé Besson, Wendyl D'Souza, et al.
Epilepsia Open|March 10, 2023
The phenotypic and genotypic spectrum of epilepsy and intellectual disability in adults: Implications for genetic testingSophie von Brauchitsch, Denise Haslinger, Silvia Lindlar, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 21, 2016
Estimating the Quantitative Demand of NOAC Antidote Doses on Stroke UnitsWaltraud Pfeilschifter, Dana Farahmand, Daniela Niemann, et al.
Journal of Neurology|March 4, 2024
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysisJerzy P Szaflarski, Hervé Besson, Wendyl D'Souza, et al.
Der Nervenarzt|January 30, 2019
[Acceptance, demand, reasons for consultation and outcome of counseling on epilepsy in Hesse and Lower Franconia]Jacqueline M Kondziela, Juliane Schulz, Bernhard Brunst, et al.
Neurological Research and Practice|June 6, 2022
Exploring the relationships between composite scores of disease severity, seizure-freedom and quality of life in Dravet syndromeAdam Strzelczyk, Gerhard Kurlemann, Thomas Bast, et al.
Pageof 30

Showing results (241-250 of 295) with videos related to

Sort By:
Pageof 30
Epilepsia|October 19, 2016
Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from GermanyLena-Marie Kortland, Anne Alfter, Oliver Bähr, et al.
Critical Care Medicine|August 28, 2023
The Long-Term Use of Diagnostic Subdural Electroencephalogram Electrodes and Subdural Hematoma: A Prospective Cohort StudySae-Yeon Won, Thomas M Freiman, Sara Sujin Lee-Müller, et al.
Epilepsia|August 4, 2015
Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in GermanyJanna Riechmann, Adam Strzelczyk, Jens P Reese, et al.
Epilepsy & Behavior : E&B|October 25, 2019
Can commercially available wearable EEG devices be used for diagnostic purposes? An explorative pilot studyYannic Titgemeyer, Rainer Surges, Dirk-Matthias Altenmüller, et al.
Epilepsy & Behavior : E&B|July 6, 2024
Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studiesEdward Faught, Hervé Besson, Wendyl D'Souza, et al.
Epilepsia Open|March 10, 2023
The phenotypic and genotypic spectrum of epilepsy and intellectual disability in adults: Implications for genetic testingSophie von Brauchitsch, Denise Haslinger, Silvia Lindlar, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 21, 2016
Estimating the Quantitative Demand of NOAC Antidote Doses on Stroke UnitsWaltraud Pfeilschifter, Dana Farahmand, Daniela Niemann, et al.
Journal of Neurology|March 4, 2024
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysisJerzy P Szaflarski, Hervé Besson, Wendyl D'Souza, et al.
Der Nervenarzt|January 30, 2019
[Acceptance, demand, reasons for consultation and outcome of counseling on epilepsy in Hesse and Lower Franconia]Jacqueline M Kondziela, Juliane Schulz, Bernhard Brunst, et al.
Neurological Research and Practice|June 6, 2022
Exploring the relationships between composite scores of disease severity, seizure-freedom and quality of life in Dravet syndromeAdam Strzelczyk, Gerhard Kurlemann, Thomas Bast, et al.
Pageof 30